Blog Tag: Diabetic Foot Ulcers

Harbor MedTech Announces Market Launch of Architect™ Collagen Matrix

Harbor MedTech, Inc., announced today FDA clearance for its first product, Architect™, which it describes as an advanced collagen matrix for treatment of skin wounds.  In the press release, Harbor MedTech President and Founder Jerry Mezger states that:

[T]he FDA has cleared Architect™ for treating a wide variety of serious skin wounds, including diabetic foot ulcers, venous leg ulcer, pressure ulcers, and many other trauma or surgery related skin wounds[.]

According to the press release, shipments of the device will begin in April.  Harbor MedTech is a medical device company based in Irvine, California.  Harbor MedTech’s press release is available here.